Extracorporeal carbon dioxide removal for acute hypercapnic respiratory failure

Luis Morales-Quinteros, Lorenzo Del Sorbo, Antonio Artigas

Research output: Contribution to journalReview articleResearchpeer-review

8 Citations (Scopus)


© 2019, The Author(s). In the past, the only treatment of acute exacerbations of obstructive diseases with hypercapnic respiratory failure refractory to medical treatment was invasive mechanical ventilation (IMV). Considerable technical improvements transformed extracorporeal techniques for carbon dioxide removal in an attractive option to avoid worsening respiratory failure and respiratory acidosis, and to potentially prevent or shorten the duration of IMV in patients with exacerbation of COPD and asthma. In this review, we will present a summary of the pathophysiological rationale and evidence of ECCO2R in patients with severe exacerbations of these pathologies.
Original languageEnglish
Article number79
JournalAnnals of Intensive Care
Issue number1
Publication statusPublished - 1 Dec 2019


  • Asthma
  • COPD
  • ECCO R 2
  • Invasive mechanical ventilation
  • Noninvasive mechanical ventilation


Dive into the research topics of 'Extracorporeal carbon dioxide removal for acute hypercapnic respiratory failure'. Together they form a unique fingerprint.

Cite this